Four Off-Label Medications for Long Covid to be Reimbursed by Health Insurers

In Germany, a decision has been made to reimburse four medications for Long Covid and Post-Covid by health insurance companies, despite them being approved for other indications, as there are currently no approved drugs specifically for these conditions.